CORC

在结果中检索

CORC

浏览/检索结果: 共215条，第1-10条 帮助

限定条件    
已选(0)清除 条数/页：   排序方式：
Towards microfluidic-based optical encryption using superhydrophobic surfaces created by femtosecond laser ablation 会议论文
Jiaxing, China, July 27-31, 2021
作者:  Zheng JC(郑建辰);  Yu HB(于海波);  Wen YD(文扬东);  Zhao WX(赵文秀);  Luo H(罗昊)
收藏  |  浏览/下载：7/0  |  提交时间：2021/11/27
Simultaneous depth and viscoelasticity measurement of micro-structures using echo effect in a photoacoustic imaging system 会议论文
Sanya, China, December 27-31, 2021
作者:  Zhao WX(赵文秀);  Yu HB(于海波);  Wen YD(文扬东);  Wang XD(王晓朵);  Liu LQ(刘连庆)
收藏  |  浏览/下载：8/0  |  提交时间：2022/05/02
Diamine molecules double lock-link structured graphene oxide sheets for high-performance sodium ions storage 会议论文
作者:  Zhang, Yu-Shan;  Zhang, Bin-Mei;  Hu, Yu-Xia;  Li, Jun;  Lu, Chun
收藏  |  浏览/下载：16/0  |  提交时间：2020/12/18
Design of suppressing optical and recombination losses in ultrathin CuInGaSe2 solar cells by Voronoi nanocavity arrays 会议论文
作者:  Wang, Yi-Chung;  Chen, Chia-Wei;  Su, Teng-Yu;  Yang, Tzu-Yi;  Liu, Wen-Wu
收藏  |  浏览/下载：11/0  |  提交时间：2020/12/18
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：45/0  |  提交时间：2019/12/05
Wideband Direction Finding via Spatial Decimation and Coupled Canonical Polyadic Decomposition 会议论文
16th International Symposium on Neural Networks, ISNN 2019, Moscow, Russia, 2019-07-10
作者:  Yu, Gui-Chen;  Gong, Xiao-Feng;  Jiang, Jia-Cheng;  Liu, Zhi-Wen;  Xu, You-Gen
收藏  |  浏览/下载：3/0  |  提交时间：2019/12/02
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：35/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：36/0  |  提交时间：2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：32/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：29/0  |  提交时间：2019/12/05

©版权所有 ©2017 CSpace - Powered by CSpace